Procter & Gamble Company
NYSE: PG
$172.32
+$0.78 (+0.5%)
Real Time Data Delayed 15 Min.
PG Articles
Earnings season hits its stride next week and here are previews of four companies reporting March quarter results early Tuesday.
Published:
These five BofA Securities high-quality stock picks have good prospects for the rest of 2021 and should continue to be accompanied by dependable dividends. They may be an alternative for conservative...
Published:
The Thursday afternoon analyst calls were focused on Apple, Bed Bath & Beyond, Procter & Gamble, Snap, SiriusXM and more.
Published:
Streaming video powerhouse Netflix reports quarterly and annual results after markets close Tuesday, and three other investor favorites are on the calendar for Wednesday morning.
Published:
There are some mergers which obviously need to be blocked. After all, if a company becomes a monopoly or can become far more predatory in an industry then it can cause problems for other businesses...
Published:
Tuesday's top analyst upgrades and downgrades included Clorox, Coca-Cola, Colgate-Palmolive, Garmin, Jabil, Newell Brands, Palo Alto Networks, Pepsico, Procter & Gamble and Smartsheet.
Published:
When investors are this optimistic, it usually portends a sizable downturn. These five consumer staples companies always remain popular with consumers, and their stocks make sense for growth...
Published:
These four top stocks offer investors with a longer time horizon solid value and outstanding entry points. All make good sense for those looking to leave pricier growth stocks, and all four companies...
Published:
Procter & Gamble reported better than expected fiscal first-quarter financial results before the markets opened on Thursday.
Published:
Nearly a third of the Dow Jones industrial average components are scheduled to report their latest quarterly reports this week, including Coca-Cola, Inte and Verizon.
Published:
These four consumer staples stocks make sense as we start the fourth quarter. After the big gains investors have seen this year, it makes sense to take some profits and reset with more conservative...
Published:
Consumer products giant Nestlé has agreed to acquire Aimmune Therapeutics, maker of a peanut-allergy treatment. The deal is valued at $2.6 billion, including Nestlé's existing stake Aimmune.
Published:
Procter & Gamble reported better than exepcted fiscal fourth-quarter financial results before the markets opened on Thursday.
Published:
Jefferies analysts have named 10 companies they think have a solid chance of posting second-quarter results that exceed current Wall Street consensus estimates.
Published:
Monday's top analyst upgrades and downgrades included Albermarle, Biogen, Dun & Bradstreet, eBay, First Solar, Lemonade, Morgan Stanley, Procter & Gamble, Schlumberger and Verizon Communications.
Published: